Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Warnecke, Richard B.

Richard B. Warnecke, PhD

Professor Emeritus of Epidemiology, Public Administration and Sociology

Member, UI Cancer Center


Building & Room:

472 Westside Research Office Bldg.


1747 West Roosevelt Road Chicago, IL 60608

Office Phone:

(312) 355-1167


Dr. Warnecke has been actively involved as a researcher in cancer control for more than 40 years. He has a long-standing relationship with the National Cancer Institute (NCI), as both a principal investigator and a grant reviewer. He received one of the first Cancer Control Science Program Grants ever awarded by NCI, which was among the first grants of IHRP, in its early days as the Prevention Research Center back in 1986. He is recognized as an IHRP Fellow.

He also led the scientific teams that were among the first recipients of the five-year Center for Population Health and Health Disparities grants award by the NCI in 2003. He was one of three original investigators whose center grant was renewed for a second five-year period in 2010. He has published two books and more than 90 articles concerned with cancer control topics.


Research Interests

Cancer prevention and epidemiology and health disparities as they relate to cancer management

Selected Publications

For a more detailed list of publications by Dr. Richard Warnecke, see this edited list on PubMed.

Simon MA, Fitzgibbon M, Ciecierski C, Cooper JM, Martinez E, Tom L, et al. Building Cross-Institutional Collaborative Infrastructure and Processes: Early Lessons From the Chicago Cancer Health Equity Collaborative. Prog Community Health Partnersh. 2019;13(5):5-13. doi: 10.1353/cpr.2019.0030.

Warnecke RB, Campbell RT, Vijayasiri G, Barrett RE, Rauscher GH. Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev. 2019;28(1):59–66. doi:10.1158/1055-9965.EPI-17-0945. [See abstract.]

Hoskins KF, Tejeda S, Vijayasiri G, et al. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center. Cancer. 2018;124(18):3733–3741. doi:10.1002/cncr.31635. [See abstract.]

Molina Y, Kim SJ, Berrios N, et al. Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study. J Womens Health (Larchmt). 2018;27(3):317–323. doi:10.1089/jwh.2016.6120. [See abstract.]

Tejeda S, Stolley MR, Vijayasiri G, et al. Negative psychological consequences of breast cancer among recently diagnosed ethnically diverse women. Psychooncology. 2017;26(12):2245–2252. doi:10.1002/pon.4456. [See abstract.]

Rauscher GH, Campbell RT, Wiley EL, Hoskins K, Stolley MR, Warnecke RB. Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors. Am J Epidemiol. 2016 May 15;183(10):884-93. [See abstract.]

Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF. Cancer risk assessment among low-income women of color in primary care: a pilot study. J Oncol Pract. 2015 Jul;11(4):e460-7. [See abstract.]

Mortel M, Rauscher GH, Murphy AM, Hoskins K, Warnecke RB. Racial and ethnic disparity in symptomatic breast cancer awareness despite a recent screen: the role of tumor biology and mammography facility characteristics. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1599-606. [See abstract.]

Curry SJ, Mermelstein RJ, Emery SL, Sporer AK, Berbaum ML, Campbell RT, Flay B, Warnecke RB. A national evaluation of community-based youth cessation programs: end of program and twelve-month outcomes. Am J Community Psychol. 2013 Mar;51(1-2):15-29. [See abstract.]

Freeman VL, Ricardo AC, Campbell RT, Barrett R, Warnecke R. Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2150-2159. [See abstract.]

Manfredi C, Cho YI, Warnecke R, Saunders S, Sullivan M. Dissemination strategies to improve implementation of the PHS smoking cessation guideline in MCH public health clinics: Experimental evaluation results and contextual factors. Health Educ Res. 2011 Apr;26(2):348-60. [See abstract.]

Cho YI, Johnson TP, Barrett RE, Campbell RT, Dolecek TA, Warnecke RB. Neighborhood Changes in Concentrated Immigration and Late Stage Breast Cancer Diagnosis. J Immigr Minor Health. 2011 Feb;13(1):9-14. [See abstract.]

Kaiser K, Rauscher GH, Jacobs EA, Strenski TA, Ferrans CE, Warnecke RB. The import of trust in regular providers to trust in cancer physicians among white, African American, and Hispanic breast cancer patients. J Gen Intern Med. 2011 Jan;26(1):51-7. [See abstract.]

Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun E, Warnecke RB. Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):640-7. [See abstract.]

Emery S, Lee J, Curry SJ, Johnson T, Sporer AK, Mermelstein R, Flay B, Warnecke R. Finding needles in a haystack: a methodology for identifying and sampling community-based youth smoking cessation programs. Eval Rev. 2010 Feb;34(1):35-51. [See abstract.]


Notable Honors

2010 Health & Medicine Policy Research Group Award for Research
IHRP Fellow